beta-naphthoflavone has been researched along with Breast Cancer in 5 studies
beta-Naphthoflavone: A polyaromatic hydrocarbon inducer of P4501A1 and P4501A2 cytochromes. (Proc Soc Exp Biol Med 1994 Dec:207(3):302-308)
beta-naphthoflavone : An extended flavonoid resulting from the formal fusion of a benzene ring with the f side of flavone.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The effect of arylhydrocarbon receptor agonist beta-naphthoflavone on the content of 8-hydroxy-2-deoxyguanosine and number of estrogen and progesterone receptors was evaluated in MCF-7 breast cancer cells." | 7.73 | Content of 8-hydroxy-2-deoxyguanosine in steroid receptor-positive and receptor-negative breast cancer cells. ( Bershtein, LM; Levina, VV; Poroshina, TE; Tsyrlina, EV, 2005) |
| " The effect of arylhydrocarbon receptor agonist beta-naphthoflavone on the content of 8-hydroxy-2-deoxyguanosine and number of estrogen and progesterone receptors was evaluated in MCF-7 breast cancer cells." | 3.73 | Content of 8-hydroxy-2-deoxyguanosine in steroid receptor-positive and receptor-negative breast cancer cells. ( Bershtein, LM; Levina, VV; Poroshina, TE; Tsyrlina, EV, 2005) |
| "Thus, some human breast tumors had AHH activity exceeding that in rat liver." | 1.26 | Aryl hydrocarbon hydroxylase activity in mouse, rat, and human mammary tumors. ( Mason, ME; Okey, AB, 1981) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (20.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wang, C | 1 |
| Xu, CX | 1 |
| Bu, Y | 1 |
| Bottum, KM | 1 |
| Tischkau, SA | 1 |
| Hanioka, N | 1 |
| Iwabu, H | 1 |
| Hanafusa, H | 1 |
| Nakada, S | 1 |
| Narimatsu, S | 1 |
| Bershtein, LM | 1 |
| Levina, VV | 1 |
| Poroshina, TE | 1 |
| Tsyrlina, EV | 1 |
| Nwankwo, JO | 1 |
| Mason, ME | 1 |
| Okey, AB | 1 |
5 other studies available for beta-naphthoflavone and Breast Cancer
| Article | Year |
|---|---|
Beta-naphthoflavone (DB06732) mediates estrogen receptor-positive breast cancer cell cycle arrest through AhR-dependent regulation of PI3K/AKT and MAPK/ERK signaling.
Topics: Base Sequence; beta-Naphthoflavone; Breast Neoplasms; Cell Cycle; Cell Line, Tumor; DNA Primers; Ext | 2014 |
Expression and inducibility of UDP-glucuronosyltransferase 1As in MCF-7 human breast carcinoma cells.
Topics: beta-Naphthoflavone; Breast Neoplasms; Cell Line, Tumor; Dexamethasone; Enzyme Induction; Female; Ge | 2012 |
Content of 8-hydroxy-2-deoxyguanosine in steroid receptor-positive and receptor-negative breast cancer cells.
Topics: 8-Hydroxy-2'-Deoxyguanosine; beta-Naphthoflavone; Breast Neoplasms; Deoxyguanosine; DNA Damage; Estr | 2005 |
Significant transcriptional down-regulation of the human MDR1 gene by beta-naphthoflavone: a proposed hypothesis linking potent CYP gene induction to MDR1 inhibition.
Topics: 3T3 Cells; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; beta-Naphthoflavone; Br | 2007 |
Aryl hydrocarbon hydroxylase activity in mouse, rat, and human mammary tumors.
Topics: Animals; Aryl Hydrocarbon Hydroxylases; Benzo(a)pyrene; Benzoflavones; Benzopyrenes; beta-Naphthofla | 1981 |